Annual Report

 



Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Craig Marks

Finance, Fixed Income, M&A

Henry Wheeler

Oncology

Mitchell Chan

Oncology

Nick Stone

Respiratory, Brilinta

Christer Gruvris

Diabetes, Autoimmunity, Neuroscience & Infection

US general enquiries


  • Annual Reports

    Our Annual Report provides a wide range of information about our global business.


  • Shareholder FAQs

    Answers to frequently asked shareholder questions.


  • Our Pipeline

    Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development